Multi-Institutional Evaluation of Curative Intent Chemoradiotherapy for Patients with Clinical T1N0 Esophageal Adenocarcinoma
Krishan R. Jethwa(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Harry H. Yoon(Mayo Clinic), Michael G. Haddock(Mayo Clinic in Arizona), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Karthik Gonuguntla(Mayo Clinic in Arizona), Weiye Deng(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), Mariela Blum Murphy(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2019
Cited by 2
Related Papers
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Neuropeptide S
|Neuron|2004|516